US Federal Circuit reverses and remands 2008 Mirapex patent validity opinion
03 February 2010
Nancy Faigen
A federal appeals court has handed a win to
Boehringer Ingelheim in a patent infringement case, and has reversed and remanded a 2008 ruling from a lower court that invalidated a US patent related to the company's Parkinson's disease treatment, Mirapex (pramipexole dihydrochloride), for obviousness-type...
Please Login to read the full article.
03 February 2010
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pfizer's 'non obvious' Viagra patents good until 2019 to fend off Teva in US
- Shionogi "incompetence" strengthens AstraZeneca's $10bn Crestor patent
- Lilly wins appeal in patent fight over ADHD drug Strattera
- US Capitol Capsule: Court rulings in gene patent, stem cell cases provide new hope for biopharma
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
